UAE named among highest-trust nations for health and AI in Edelman 2026 survey of 28 countries

The Edelman 2026 Trust Barometer confirmed the UAE among the world's highest-trust nations for health institutions and artificial intelligence, according to findings published on 10 June 2026. The annual survey, covering 28 countries, places the UAE in a cluster of high-trust economies where institutional confidence in healthcare and emerging technology is measurably above the global average.

What trust data means for operators

Institutional trust in healthcare translates directly to patient consent rates for digital data sharing, uptake of AI-assisted diagnostic tools, and engagement with telemedicine platforms. The UAE's placement in the Edelman rankings puts it alongside Nordic and East Asian markets where digital health adoption has consistently outpaced global averages, a position operators can use to push AI pilot approvals faster and lift patient app engagement.

For hospital groups and clinic networks, a high-trust environment removes friction at the point of digital service delivery. Patients who trust health institutions are more likely to share wearable data and accept AI-generated clinical recommendations, supporting the precision medicine and population health programs that Cleveland Clinic Abu Dhabi, Mediclinic Middle East, and the Emirates Health Services network have been expanding since 2023. The practical effect is faster patient onboarding for new digital services and lower dropout rates in remote monitoring programs.

MOHAP's governance as the trust engine

The UAE's high trust scores trace to specific regulatory decisions by three bodies:

• MOHAP established a unified telemedicine licensing framework with cross-emirate quality standards, closing a gap that left patients in the Northern Emirates without consistent assurance for remote consultations.
• DHA requires clinical validation evidence before AI diagnostic tools are deployed in licensed facilities in Dubai.
• DOH ties AI procurement in Abu Dhabi to defined patient safety benchmarks under its digital transformation roadmap.

That regulatory friction slowed market entry for health tech startups, but appears to have protected the institutional credibility the Edelman data now reflects.

Implications for health tech investment and operators

For health technology founders and investors, a high-trust operating environment reduces customer acquisition costs and compresses procurement cycles. UAE health systems that trust AI approve pilots faster and face less internal resistance from clinical staff. The Edelman finding is consistent with the UAE AI Strategy 2031, which names healthcare as a priority deployment sector for AI and a direct contributor to non-oil GDP growth targets.

The counterpoint is complacency. Trust earned through careful regulation erodes quickly after a high-profile AI failure or a patient data breach. Both the DOH and DHA have issued cybersecurity compliance frameworks for licensed facilities, but enforcement maturity varies across emirate-level authorities. Operators who read the Edelman ranking as license to accelerate AI deployment without matching governance investment may find that trust is more fragile than a single survey implies.